Dividend on the way · $0.01
Embecta
Sells pen needles, syringes, and newer drug-delivery devices for diabetes and chronic care.
$5.01
After-hours close−0.04 (−0.79%)
At close$5.05(+1.61%)
| Date | Estimate | Reported | Surprise |
|---|---|---|---|
| Nov 2026 | $0.31 | — | — |
| Aug 2026 | $0.27 | $0.56 | +110.7% |
| May 2026 | $0.42 | $0.27 | −35.7% |
| Feb 2026 | $0.67 | $0.71 | +6.0% |
| Nov 2025 | $0.70 | $0.50 | −28.6% |
The latest year is open to everyone — the 20 quarters behind it read with an account. Sign in | |||
| Aug 2025 | |||
| May 2025 | |||
| Feb 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Feb 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Feb 2023 | |||
| Dec 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Mar 2022 | |||
| Nov 2021 | |||
| Aug 2021 | |||
| May 2021 | |||
| Feb 2021 | |||
| Nov 2020 | — | — | — |
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise |
|---|---|---|---|---|---|---|
| Nov 24, 2026 | $0.31 | — | — | $269.7M | — | — |
| Aug 7, 2026 | $0.27 | $0.56 | +110.7% | $254.5M | $271.7M | +6.7% |
| May 5, 2026 | $0.42 | $0.27 | −35.7% | $235.7M | $221.8M | −5.9% |
| Feb 5, 2026 | $0.67 | $0.71 | +6.0% | $258.1M | $261.2M | +1.2% |
| Nov 25, 2025 | $0.70 | $0.50 | −28.6% | $258.2M | $264.0M | +2.2% |
The latest year is open to everyone — the 20 quarters behind it read with an account. Sign in | ||||||
| Aug 8, 2025 | ||||||
| May 9, 2025 | ||||||
| Feb 6, 2025 | ||||||
| Nov 26, 2024 | ||||||
| Aug 9, 2024 | ||||||
| May 9, 2024 | ||||||
| Feb 9, 2024 | ||||||
| Nov 21, 2023 | ||||||
| Aug 8, 2023 | ||||||
| May 12, 2023 | ||||||
| Feb 14, 2023 | ||||||
| Dec 20, 2022 | ||||||
| Aug 15, 2022 | ||||||
| May 13, 2022 | ||||||
| Mar 16, 2022 | ||||||
| Nov 14, 2021 | ||||||
| Aug 14, 2021 | ||||||
| May 15, 2021 | ||||||
| Feb 14, 2021 | ||||||
| Nov 14, 2020 | — | — | — | — | — | — |